Skip to main content

2 April 2023

Last updated: Tuesday 28 March 2023

User account anon menu

Login
Register and subscribe

Search

Home
News
About MedNous
Research Directory
Contact Us
- Contact Form

Menu

Breadcrumb

Home
Research Directory

Research Directory

Build-to-buy model attracts Pharma investors

Tuesday 26 August 2014

Interviewee/Contributor

Clare Ozawa

Organisation

Inception Sciences Inc

Organisations

4-Antibody AG
Bicycle Therapeutics Ltd
BC Platforms AG
Hutchison China MediTech
Cellzome
PolyTherics Ltd
Medical Marketing International Group plc
ADC Therapeutics SA
Noxxon Pharma AG
Humabs BioMed SA

Interviewees and Contributers

Patricia Hurley
Henrik Jensen
José Baselga
Nigel Gaymond
William Ellington
Francesco De Rubertis
Tim Sturgeon and Martin Gouldstone
Nick Ray
Helen Boucher
Michael E. Hunt

Select a News Category

Clinical Research
Company News
Finance, Grants, Deals
IPR & Legal
Regenerative Medicine
Regulation & Policy
Research & University News

Recent Appointments

Medivir has new CMO

Sunday 19 March 2023

New advisory board member at Pan Cancer T

Sunday 19 March 2023

Osivax appoints Chris Martin to board

Sunday 19 March 2023

Two changes to Novo Nordisk executive team

Sunday 19 March 2023

New deputy director at the FDA

Sunday 19 March 2023

View more appointments

Looking for more?

MedNous covers medical news and more. See more in our various site sections.

News
Industry appointments
Events
Research directory
Subscribe

Footer

Privacy policy

© 2023 Evernow Publishing Ltd.

Home
News
- News
- Appointments
- Events
About MedNous
Research Directory
Contact Us
- Contact Form